Brief

Manufacturers of joint replacement implants are required to report adverse incidents related to their products. This guidance outlines the specific procedures for doing so, in conjunction with MEDDEV 2.12/1 guidelines on a medical devices vigilance system. The focus is on incident reporting obligations for manufacturers of these implants. Adverse events such as device failure, infection, or other complications must be documented and reported to regulatory authorities as per established protocols.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies